The head of the Food and Drug Administration (FDA) explained the agency’s progress in establishing regulations for CBD in response to questioning from a pair of bipartisan lawmakers at a congressional hearing on Wednesday. FDA Commissioner Stephen Hahn discussed enforcement actions the agency has taken against companies that have made unsanctioned claims about the medical … Continue reading FDA Chief Faces CBD Questions At Congressional Hearing